WWE 2K20 Announces Partnership With The Leukemia & Lymphoma Society

Advertisement

WWE 2K20 will partner with the Leukemia & Lymphoma Society on a global marketing strategy.

2K has announced they will partner with The Leukemia & Lymphoma Society on a global marketing campaign “to support breakthrough blood cancer research to advance lifesaving treatments and critical support for patients and their families.”

2K will donate $2 for every re-tweet of @WWEGames up to a maximum of $500,000 to the Leukemia and Lymphoma Society. They will also be providing the game to patients and co-ordinate hospital visits with WWE Superstars. The company is asking people to please help spread this donation link so others can donate as well.

WWE 2K20 is scheduled to be released on October 22nd, 2019.

WWE 2K20 Partners With Leukemia & Lymphoma Society

- Advertisement -

WWE announced the news today in a press release.

“Partnering with The Leukemia & Lymphoma Society, the global non-profit leader in the fight against blood cancers, is a natural extension of our WWE 2K20 relationship with WWE and Roman Reigns and an opportunity for us to give back to the community, raise awareness and join the fight to find a cure,” said Chris Snyder, Vice President of Marketing for 2K. “Roman’s strength and perseverance to win his battle with leukemia is truly inspiring to all of us, and we are proud to feature him on both the cover of WWE 2K20 and through a dedicated 2K Tower celebrating his incredible career journey.”

“As an organization founded 70 years ago by a family who lost their 16-year-old son to leukemia, we are committed to finding cures and helping families affected by cancer, through our investment in research, free patient support services and financial support, and by advocating for laws that provide access to quality, affordable care,” explains Louis J. DeGennaro, PhD, LLS president and CEO. “We are pleased to reach a new generation of families through this exciting partnership with 2K and we are grateful for their support of our quest to end blood cancers.”